Earlier this year, HST Global announced that it contracted EBITDA Capital LLC of Newport Beach California and its group of associates to join HST-Global’s efforts in working toward an overall corporate strategy. The company also announced Former United States Congressman Bill Sarpalius, the President and CEO of Advantage Associates International, has been given the role of interfacing with the political community in Washington DC.
Mr. Sarpalius said, “We are excited to be in a position to raise the awareness of both the public and members of the government about HST’s treatment solution. The opportunity of bringing a treatment for late stage cancer is something which we all want to see expanded and made use of in the treatment community.”
Mr. Ron Howell, CEO and President of HST Global commented, “Through the use of the EBITDA Capital resources we at HST Global can focus on the issue of bringing awareness of our treatment and solution for late stage cancer treatment. We want to insure that our treatment is being given every opportunity to be recognized as the medical solution alternative of choice.”
“HST has worked to develop a complete strategy for the success of its program and treatment and is now moving toward a more public awareness platform. We believe that EBITDA and its associates, such as Advantage Associates, will help us get this done,” he continued.
About QualityStocks:
QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.
Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
The Quality Stocks Daily Stock Report http://video.qualitystocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment